Acridone-based acetylcholinesterase inhibitors; synthesis, antioxidant activity and molecular modeling
Keywords:
Acridone, antiacetylcholinesterase, antioxidant, docking, Alzheimer’s disease, Molecular DockingAbstract
Acridone is a unique naturally occurring alkaloid known to associate with several biological activities. 2,3-dimethoxy-10-methyl-10, 8a-dihydroacridin-9 (8aH)-one (4) and its precursor 2- ((3,4-dimethoxyphenyl)methylamino)benzoic acid (3) were synthesized and investigated for potential antioxidant and inhibitory activity against acetylcholinestrase. The synthetic pathway involves reaction of 2-(methylamino) benzoic acid (1) with 4-chloro-1,2-dimethoxybenzene (2) in presence of CuO and K2CO3 to give the precursor 3. Subsequent, cyclcondensation of 3 with Conc. H2SO4 afforded the anticipated acridone 4. Furthermore, the dimethoxyacridone derivative 4 showed potent antiacetylcholinesterase (ACHE) activity at (100 uM) with IC50 = 9.25 uM that is as potent as the reference drug rivastigmine. Assessment of total antioxidant activity of compounds 3 & 4 in comparison to known standard compounds revealed the following order: α-tocopherol > Acridone 4 > trolox > butylated hydroxyl anisole (BHA) > butylated hydroxyl toluene (BHT) > compound 3. Molecular docking characteristics of 3 & 4 within the active site of AChE (PDB: 1ACJ) cocrystallized with 9-amino-tetrahydroacridine (Tacrine) have been studied. Interestingly, the results revealed comparable binding poses to the co-crystallized ligand and demonstrates good correlation of the binding energy (DG) with the observed IC50-values. This finding suggests that compounds 3 & 4 exhibit good antioxidant effect and inhibition of acetylcholinesterase, which might provide profitable candidates in management of Alzheimer’s disease.
References
Guntupalli C, Kumar GS, Kumar AS, Tubati T. Evaluation of antioxidant activity of the methanolic leaf extract
Clausena excavate Burm. F. (Rutaceae) using lipid peroxidation. Phcog J. 2012;2012:4–34.
Asadipour A, Alipour M, Jafari M. Khoobi M, Emami S,
Nadri H, Sakhteman A, Moradi A, Sheibani V, Moghadam
FH, Shafiee A, Foroumadi A. “Novel coumarin-3-
carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors”. Eur J Med
Chem;70:623–630.
Alipour M, Khoobi M. Moradi A, Nadri H, Moghadam
FH, Emami S, Hasanpour Z, Foroumadi A, Shafiee
A.“Synthesis and anti-cholinesterase activity of new 7-
hydroxycoumarin derivatives”. Eur J Med Chem.
;82:536–544.
Takasugi H, Kuno A, Ohkubo M. Oxadiazole derivatives
having acetylcholinesterase-inhibitory and muscarinic agonist activity. US Patent. 1997;5622976.
Khanaposhtani MM. Saeedi M, Mahdavi M, Zafarghandi
NS, Sabourian R, Razkenari EK, Alinezhad H, Khanavi
M, Foroumadi A, Shafiee A, Akbarzadeh T. “Potent
acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to
,2,3-triazole derivatives”. Eur J Med Chem;92:799–806.
Mann FG, Saunders BC. “Practical Organic Chemistry”. A
New Impression Publication; 2007.
Galdino-Pitta M, Pitta M, Lima M. Niche for acridine derivatives in anticancer therapy. Mini Rev Med
Chem;13:1256–71.
Bora RO, Dar B. Pradhan V. Farooqui. 2014;1(2):4–14.
Wang C, Wan J, Mei Z. Yang X. “Acridone alkaloids
with cytotoxic and antimalarial activities from Zanthoxylum simullans Hance”. Pharmacogn Mag;2014:10–37.
Demeunynck M, Charmantray F, Martelli A. Interest of
acridine derivatives in the anticancer chemotherapy. Curr
Pharm Des;7:1703–24.
Egloff MP, Decroly E, Malet H, Selisko B, Benarroch D,
Ferron F. Structural and functional analysis of methylation
and 5’-RNA sequence requirements of short capped RNAs
by the methyltransferase domain of dengue virus. NS5 J
Mol Biol;372:723–36.
Wainwright M. Acridine; a neglected antibacterial chromophore. J Antimicrob Chemother;47:1–13.
Hussein MA. Synthesis of some novel triazoloquinazolines and triazinoquinazolines and their evaluation
for anti-inflammatory activity. Medicinal Chemistry
Research;2012(21):1876–1886.
Hussein MA. Synthesis, anti-inflammatory, and structure
antioxidant activity relationship of novel 4-quinazoline.
Medicinal Chemistry Research;22:4641–4653.
Akrami H. Mirjalili BF, Khoobi M, Nadri H, Moradi
A, Sakhteman A, Emami S, Foroumadi A, Shafiee A.
“Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling”. Eur J
Med Chem. 2014;84:375–381.
Pudlo M, Luzet V. Ismaıli L, Tomassoli I, Iutzeler
A, Refouvelet B. “Quinolone–benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease”. Bioorg Med
Chem;2014:22–2496.
Johnson G, Moore SW. The peripheral anionic site of
acetylcholinesterase: structure, functions and potential role
in rational drug design. vol. 12. Curr Pharm Des; 2006.
Lewis WG, Green LG, Grynszpan F, Radic Z, PR C, Taylor
P, et al.. IntEngl AC, editor. Sharpless KB. Click chemistry
in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array
of building blocks; 2002.
Khanaposhtani MM, Mahdavi M. Saeedi M, Sabourian
R, Safavi M, Khanavi M, Foroumadi A, Shafiee A
and Akbarzadeh T. “Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors. New Acridone-1,2,4-oxadiazole-1,2,3-triazole
Hybrids” Chem Biol Drug;2015:86–1425.
Hanoun JP, Tensglia A. A convenient synthesis of Narylanthranilic acid using Ultrasound in the UllmannGoldberg condensation. Synth Commun;1995:25–16.
Zdrazilova P, Stepankova P, Komers S, Ventura K, Cegan
K. A. Half-inhibition concentrations of new cholinesterase
inhibitors. Z Naturforsch;2004:59–293.
Oyaizu M. Studies on products of browning reaction prepared from glucoseamine. Jpn J Nutr;1986:44–307.
Takashira M. Ohtake Y. “A new antioxidative 1,3-
benzodioxole from Melissa officinalis”. Planta Med; 1998.
Osawa T, Namiki N. A novel type of antioxidant isolated from leaf wax of Eucalyptus leaves. Agr Biol
Chem;1981:45–735.
Decker EA, Welch B. Role of ferritin as a lipid oxidation
catalyst in muscle food. J Agr Food Chem. 1990;38:674–
Ellman GL, Courtney KD, Andres V. A New and Rapid
Colorimetric Determination of Acetylcholinesterase Activity. Biochem Pharmacol. 1961;7:88–95.
Kwok SO, Wang KC, Kwok HB. An improved method to
determine SH and -S-S- group Content in soymilk protein.
Food Chem;2004:88–317.
Sinko G. Calic M, Bosak A, Kovarik Z. “Limitation of
the Ellman method: Cholinesterase activity measurement
in the presence of oximes”. Anal Biochem;2007:370–223.
Brand-Williams W, Cuvelier ME. Berset C. “Use of a free
radical method to evaluate antioxidant activity”. Lebensm
Wiss Technol. 1995;p. 28–25.
Hussein MA. El-gizawy HA, Gobba NA, Mosaad
YO. “Synthesis of Cinnamyl and Caffeoyl Derivatives
of Cucurbitacin-Eglycoside Isolated from Citrullus colocynthis Fruits and their Structures Antioxidant and Antiinflammatory Activities Relationship”. Current Pharmaceutical Biotechnology;2017(18):677–693.
Baumann J, Wurn G. Bruchlausen FV. “Prostaglandin synthase inhibiting O2- radical scavenging properties of some
flavonoids and related phenloic compounds”. N-Ss Arch
Pharmacol;1979(308):27–39.
Cao G, Sofic E, Prior RL. Antioxidant and prooxidant
behaviour of flavonoids: structure–activity relationships.
Free Rad Biol Med. 1997;p. 5–749.
Rice-Evans CA, Miller NJ, Paganga G. Structure antioxidant activity relationship of flavonoids and phenolic acids.
Free Radi Biol Med. 1996;p. 20–933.
Ales I, Sarka S, Jan V, Karel P, Juana M, Jarmila V,
et al. Acetylcholinesterase- Inhibiting Activity of Salicylanilide N-alkylcarbamates and Their Molecular Docking.
Molecules;2012:17–10142.
Ordentlich A, Barak D. Kronman C, Flashner Y, Leitner
M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A.
"Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of
residues constituting the anionic site, the hydrophobic site,
and the acyl pocket". J Biol Chem 1993;268(23):17083–
Tougu V. Acetylcholinesterase: Mechanism of Catalysis
and Inhibition. Current Medicinal Chemistry Central Nervous System Agents2001;1(2):155–170.
Harel M, Schalk I. Ehret-Sabatier L, Bouet F, Goeldner M,
Hirth C, Axelsen PH, Silman I, Sussman JL. "Quaternary
ligand binding to aromatic residues in the active-site gorge
of acetylcholinesterase"; 1993. p. 9031–5.
Lin G, Chen GH. Lu CP, Yeh SC. “QSARs for peripheral
anionic site of butyrylcholinesterase with inhibitions by
-acyloxy-biphenyl-40-N-butylcarbamates”. QSAR Comp
Sci;2005:24–943.
Lin G, Chen GH, Yeh SC. Lu CP. “Probing the peripheral anionic site of acetylcholinesterase with quantitative structure activity relationships for inhibition by
biphenyl-4-acyoxylate-40-N-butylcarbamates”. J Biochem
Mol Toxicol;19:234–243.
Kryger G, Silman I, Sussman J. Structure of acetylcholinesterase complexed with E2020 (Aricept®): Implications for the design of new anti-Alzheimer drugs.
Structure;1999:7–297.
Alonso I, Dorronsoro L, Rubio P, Munoz E. GarciaPalomero M, del Monte A, Bidon-Chanal, M, Orozco
FJ, Luque A, Castro M. “Donepezil-tacrine hybrid related
derivatives as new dual binding site inhibitors of AChE”.
Bioorg Med Chem;2005:13–6588.
